Lu Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lu Cheng has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Biwen Wang
Department of Sanitary Chemistry, School of Public Health, Guangxi Medical University, Nanning, China
2 shared publications- Han Li
Department of Sanitary Chemistry, School of Public Health, Guangxi Medical University, Nanning, China
2 shared publications Huaicai Zeng
Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guilin Medical University, Guilin, China
2 shared publicationsJiemei Li
Department of Sanitary Chemistry, School of Public Health, Guangxi Medical University, Nanning, China
2 shared publicationsJuanhua Li
Department of Public Health, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
2 shared publicationsNing Qin
Department of Sanitary Chemistry, School of Public Health, Guangxi Medical University, Nanning, China
2 shared publications
Latest Publications
- Open Access
- 11 September 2025
- Published by Springer Nature in Research Square
Trend and burden of Alzheimer's disease and other dementias in China 1990–2021: a systematic analysis with forecasts to 2035
Background: Alzheimer's Disease (AD) has become a major public health problem affecting the health of the elderly as the global population ages. This study aims to analyze the epidemiological characteristics of AD in China, predict its future trends, and explore coping strategies, with the aim of providing a scientific basis for public health policy making. Methods: Using data from the Global Burden of Disease Study 2021, this study assessed the underlying prevalence characteristics and trends in AD age-standardized incidence and mortality using a combination of joint point regression models and (Bayesian) age-period-cohort models. Results: The age-standardized incidence and mortality of AD and other dementias in China in 2021 were 151.47 /100 000 and 30.82/10 000, and the age-standardized rate of disability-adjusted life year was 562.39 /100 000. Between 1990 and 2021, the age-standardized incidence showed an increasing trend, while the age-standardized mortality declined slightly. Age is a significant risk factor for incidence and mortality in AD and other dementias, with both incidence and mortality increasing significantly with age. Period and cohort effects showed fluctuations in incidence and mortality across time and cohorts. Projection analyses suggest that the standardized incidence and mortality for AD and other dementias will increase steadily between 2022 and 2035. Conclusion: The age-standardized incidence and mortality for AD and other dementias increase significantly with age and are higher for female than for male. Despite a slight decline in mortality in recent years, the age-standardized incidence is still rising and is projected to continue to increase over the next 10 years. Suggesting that the burden of the disease on the public health system may further increase, there is an urgent need to strengthen early screening, diagnosis and interventions to cope with the growing disease burden in the future.
- 11 September 2025
- Published by Springer Nature in Research Square
Open AccessTrend and burden of Alzheimer's disease and other dementias in China 1990–2021: a systematic analysis with forecasts to 2035
Background: Alzheimer's Disease (AD) has become a major public health problem affecting the health of the elderly as the global population ages. This study aims to analyze the epidemiological characteristics of AD in China, predict its future trends, and explore coping strategies, with the aim of providing a scientific basis for public health policy making. Methods: Using data from the Global Burden of Disease Study 2021, this study assessed the underlying prevalence characteristics and trends in AD age-standardized incidence and mortality using a combination of joint point regression models and (Bayesian) age-period-cohort models. Results: The age-standardized incidence and mortality of AD and other dementias in China in 2021 were 151.47 /100 000 and 30.82/10 000, and the age-standardized rate of disability-adjusted life year was 562.39 /100 000. Between 1990 and 2021, the age-standardized incidence showed an increasing trend, while the age-standardized mortality declined slightly. Age is a significant risk factor for incidence and mortality in AD and other dementias, with both incidence and mortality increasing significantly with age. Period and cohort effects showed fluctuations in incidence and mortality across time and cohorts. Projection analyses suggest that the standardized incidence and mortality for AD and other dementias will increase steadily between 2022 and 2035. Conclusion: The age-standardized incidence and mortality for AD and other dementias increase significantly with age and are higher for female than for male. Despite a slight decline in mortality in recent years, the age-standardized incidence is still rising and is projected to continue to increase over the next 10 years. Suggesting that the burden of the disease on the public health system may further increase, there is an urgent need to strengthen early screening, diagnosis and interventions to cope with the growing disease burden in the future.
- Open Access
- 24 January 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 290, 117768
Multi-metal mixture exposure and cognitive function in urban older adults: The mediation effects of thyroid hormones
- 24 January 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 290, 117768
Open AccessMulti-metal mixture exposure and cognitive function in urban older adults: The mediation effects of thyroid hormones
- Open Access
- 9 January 2017
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 14 (1) , 58
Critical Windows of Prenatal Exposure to Cadmium and Size at Birth
Prenatal cadmium (Cd) exposure has been associated with adverse birth outcomes, but the findings of previous studies are inconsistent. We measured Cd concentrations in urine samples at or near 13, 24, and 35 gestational weeks from 282 women in Wuhan, China. We used generalized estimating equation models to assess the associations between maternal creatinine adjusted urinary Cd concentrations at each trimester and birth size. A significant inverse association was observed between higher maternal Cd levels measured during the 1st trimester and birth size in girls. For each log unit increase in Cd (µg/g creatinine) levels from the 1st trimester, there was a decrease in birth weight by 116.99 g (95% confidence interval (CI): −208.87, −25.11 g). The Cd levels from the 1st and 2nd trimesters were also borderline significantly associated with ponderal index in girls. Joint estimation of trimester-specific effects suggested that associations with Cd levels for ponderal index (pint = 0.02) were significantly different across trimesters, and differences for effects across trimesters for birth weight were marginally significant (pint = 0.08) in girls. No significant associations were observed between Cd levels from any trimester and birth size in boys. Maternal Cd exposure during earlier periods of pregnancy may have a larger impact on delayed fetal growth.
- 9 January 2017
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 14 (1) , 58
Open AccessCritical Windows of Prenatal Exposure to Cadmium and Size at Birth
Prenatal cadmium (Cd) exposure has been associated with adverse birth outcomes, but the findings of previous studies are inconsistent. We measured Cd concentrations in urine samples at or near 13, 24, and 35 gestational weeks from 282 women in Wuhan, China. We used generalized estimating equation models to assess the associations between maternal creatinine adjusted urinary Cd concentrations at each trimester and birth size. A significant inverse association was observed between higher maternal Cd levels measured during the 1st trimester and birth size in girls. For each log unit increase in Cd (µg/g creatinine) levels from the 1st trimester, there was a decrease in birth weight by 116.99 g (95% confidence interval (CI): −208.87, −25.11 g). The Cd levels from the 1st and 2nd trimesters were also borderline significantly associated with ponderal index in girls. Joint estimation of trimester-specific effects suggested that associations with Cd levels for ponderal index (pint = 0.02) were significantly different across trimesters, and differences for effects across trimesters for birth weight were marginally significant (pint = 0.08) in girls. No significant associations were observed between Cd levels from any trimester and birth size in boys. Maternal Cd exposure during earlier periods of pregnancy may have a larger impact on delayed fetal growth.